Skip to Content

1,065 Results Found

  • Review
  • Open Access
52 Citations
15,490 Views
26 Pages

14 February 2022

Virus-like particles resemble infectious virus particles in size, shape, and molecular composition; however, they fail to productively infect host cells. Historically, the presence of virus-like particles has been inferred from total particle counts...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
2 Citations
2,020 Views
19 Pages

17 April 2025

Virus-like particles are a well-established platform for vaccines, although the molecular mechanisms that underlie the extraordinary potency of many virus-like particles in eliciting strong antibody responses remain incompletely understood. Here, we...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Review
  • Open Access
75 Citations
17,713 Views
18 Pages

10 April 2021

Virus-like particles (VLPs) are increasingly used for vaccine development and drug delivery. Assembly of VLPs from purified monomers in a chemically defined reaction is advantageous compared to in vivo assembly, because it avoids encapsidation of hos...

(This article belongs to the Special Issue Capsid Protein)
  • Review
  • Open Access
164 Citations
20,342 Views
14 Pages

Recent Progress on the Versatility of Virus-Like Particles

  • Ciying Qian,
  • Xinlin Liu,
  • Qin Xu,
  • Zhiping Wang and ,
  • Jie Chen,
  • Tingting Li,
  • Qingbing Zheng,
  • Hai Yu,
  • Ying Gu and
  • Ningshao Xia
  • + 6 authors+ 1 author

20 March 2020

Virus-like particles (VLPs) are multimeric nanostructures composed of one or more structural proteins of a virus in the absence of genetic material. Having similar morphology to natural viruses but lacking any pathogenicity or infectivity, VLPs have...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Review
  • Open Access
  • Best Paper Award
72 Citations
11,111 Views
20 Pages

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines

  • Anna Lucia Tornesello,
  • Maria Tagliamonte,
  • Franco M. Buonaguro,
  • Maria Lina Tornesello and
  • Luigi Buonaguro

2 February 2022

Virus-like particles (VLPs) are self-assembled viral protein complexes that mimic the native virus structure without being infectious. VLPs, similarly to wild type viruses, are able to efficiently target and activate dendritic cells (DCs) triggering...

(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles-2nd Edition)
  • Review
  • Open Access
106 Citations
18,304 Views
24 Pages

Virus-like Particles: Fundamentals and Biomedical Applications

  • Jorge L. Mejía-Méndez,
  • Rafael Vazquez-Duhalt,
  • Luis R. Hernández,
  • Eugenio Sánchez-Arreola and
  • Horacio Bach

Nanotechnology is a fast-evolving field focused on fabricating nanoscale objects for industrial, cosmetic, and therapeutic applications. Virus-like particles (VLPs) are self-assembled nanoparticles whose intrinsic properties, such as heterogeneity, a...

(This article belongs to the Special Issue Antimicrobial Strategies in Nanomedicine)
  • Article
  • Open Access
9 Citations
3,265 Views
14 Pages

Cross-Protection Induced by Virus-like Particles Derived from the Influenza B Virus

  • Hae-Ji Kang,
  • Ki-Back Chu,
  • Keon-Woong Yoon,
  • Gi-Deok Eom and ,
  • Jie Mao and
  • Fu-Shi Quan
  • + 1 author+ 0 author

The mismatch between the circulating influenza B virus (IBV) and the vaccine strain contributes to the rapid emergence of IBV infection cases throughout the globe, which necessitates the development of effective vaccines conferring broad protection....

(This article belongs to the Special Issue New Advance in Viral Immunogens and Vaccines)
  • Review
  • Open Access
7 Citations
4,028 Views
13 Pages

Virus-like Particles for TEM Regulation and Antitumor Therapy

  • Zhu Yang,
  • Yongjie Chi,
  • Jiaxin Bao,
  • Xin Zhao and ,
  • Jing Zhang and
  • Lianyan Wang
  • + 1 author+ 0 author

17 December 2022

Tumor development and metastasis are intimately associated with the tumor microenvironment (TME), and it is difficult for vector-restricted drugs to act on the TME for long-term cancer immunotherapy. Virus-like particles (VLPs) are nanocage structure...

(This article belongs to the Section Biomaterials for Cancer Therapies)
  • Review
  • Open Access
9 Citations
12,266 Views
21 Pages

Yeast and Virus-like Particles: A Perfect or Imperfect Couple?

  • Sara Brachelente,
  • Alvaro Galli and
  • Tiziana Cervelli

Virus-like particles (VLPs) comprise viral structural proteins that self-assemble to form a particle similar to the native virus capsid. Since their discovery, they have been employed mainly as vaccines to prevent viral infection because they can eli...

(This article belongs to the Special Issue Exclusive Papers Collection of Editorial Board Members and Invited Scholars in Applied Microbiology)
  • Article
  • Open Access
4 Citations
2,654 Views
14 Pages

Chimeric Virus-like Particles of Physalis Mottle Virus as Carriers of M2e Peptides of Influenza a Virus

  • Elena A. Blokhina,
  • Eugenia S. Mardanova,
  • Anna A. Zykova,
  • Marina A. Shuklina and ,
  • Liudmila A. Stepanova,
  • Liudmila M. Tsybalova and
  • Nikolai V. Ravin
  • + 2 authors+ 0 author

20 November 2024

Plant viruses and virus-like particles (VLPs) are safe for mammals and can be used as a carrier/platform for the presentation of foreign antigens in vaccine development. The aim of this study was to use the coat protein (CP) of Physalis mottle virus...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Review
  • Open Access
68 Citations
9,297 Views
20 Pages

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines

  • Jerri C. Caldeira,
  • Michael Perrine,
  • Federica Pericle and
  • Federica Cavallo

27 April 2020

Virus-like particles (VLP) spontaneously assemble from viral structural proteins. They are naturally biocompatible and non-infectious. VLP can serve as a platform for many potential vaccine epitopes, display them in a dense repeating array, and elici...

(This article belongs to the Special Issue Virus-Like Particle Vaccines)
  • Review
  • Open Access
21 Citations
7,554 Views
17 Pages

The designer nucleases, including Zinc Finger Nuclease (ZFN), Transcription Activator-Like Effector Nuclease (TALEN), and Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated (CRISPR/Cas), have been widely used for mechanistic...

(This article belongs to the Collection Feature Papers in “Molecular Biology”)
  • Article
  • Open Access
13 Citations
17,434 Views
11 Pages

Assembly and Characterization of HBc Derived Virus-like Particles with Magnetic Core

  • Jakub Dalibor Rybka,
  • Adam Aron Mieloch,
  • Alicja Plis,
  • Marcin Pyrski and ,
  • Tomasz Pniewski and
  • Michael Giersig
  • + 1 author+ 0 author

26 January 2019

Core-virus like particles (VLPs) assembly is a kinetically complex cascade of interactions between viral proteins, nanoparticle’s surface and an ionic environment. Despite many in silico simulations regarding this process, there is still a lack...

(This article belongs to the Special Issue Virus-Based Nanomaterials and Nanostructures)
  • Article
  • Open Access
13 Citations
3,071 Views
15 Pages

A Novel Formulation of Asparaginase Encapsulated into Virus-like Particles of Brome Mosaic Virus: In Vitro and In Vivo Evidence

  • Francisca Villanueva-Flores,
  • Ana Ruth Pastor,
  • Laura A. Palomares and
  • Alejandro Huerta-Saquero

The interest in plant-derived virus-like particles (pVLPs) for the design of a new generation of nanocarriers is based on their lack of infection for humans, their immunostimulatory properties to fight cancer cells, and their capability to contain an...

(This article belongs to the Special Issue Nanocarriers for Cancer Therapy and Diagnosis, 2nd Edition)
  • Article
  • Open Access
7 Citations
4,548 Views
13 Pages

Dry Formulation of Virus-Like Particles in Electrospun Nanofibers

  • Sasheen Dowlath,
  • Katrin Campbell,
  • Farah Al-Barwani,
  • Vivienne L. Young and ,
  • Sarah L. Young,
  • Greg F. Walker and
  • Vernon K. Ward
  • + 2 authors+ 0 author

Biologics can be combined with liquid polymer materials and electrospun to produce a dry nanofibrous scaffold. Unlike spray-drying and freeze-drying, electrospinning minimizes the physiological stress on sensitive materials, and nanofiber mat propert...

(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)
  • Review
  • Open Access
8 Citations
10,866 Views
17 Pages

Virus-like Particles (VLPs) as Important Tools for Flavivirus Vaccine Development

  • Leda R. Castilho,
  • Nathalia R. Mattos,
  • Wallace S. Abreu and
  • Melissa L. E. Gutarra

31 October 2022

Flaviviruses, such as dengue, zika, yellow fever, West Nile, and Japanese encephalitis virus, are RNA viruses belonging to the Flaviviridae family (genus Flavivirus). They represent an important global health concern, since most areas of the world ar...

(This article belongs to the Section Vaccines)
  • Review
  • Open Access
103 Citations
11,842 Views
18 Pages

Virus-like Particles as Nanocarriers for Intracellular Delivery of Biomolecules and Compounds

  • Junyao He,
  • Linying Yu,
  • Xiaodi Lin,
  • Xiaoyan Liu and ,
  • Yanming Zhang,
  • Fan Yang and
  • Wen Deng
  • + 2 authors+ 0 author

28 August 2022

Virus-like particles (VLPs) are nanostructures assemble from viral proteins. Besides widely used for vaccine development, VLPs have also been explored as nanocarriers for cargo delivery as they combine the key advantages of viral and non-viral vector...

(This article belongs to the Special Issue Virus-Like Particle Vaccines 2022)
  • Review
  • Open Access
175 Citations
15,823 Views
12 Pages

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System

  • Mona O. Mohsen,
  • Ariane C. Gomes,
  • Monique Vogel and
  • Martin F. Bachmann

Virus-like particles (VLPs) derived from viral nucleocapsids are an important class of nanoparticles. The structure, uniformity, stability, and function of these VLPs have attracted scientists in utilizing them as a unique tool in various application...

  • Article
  • Open Access
6 Citations
3,650 Views
13 Pages

Plant-Produced Chimeric Hepatitis E Virus-like Particles as Carriers for Antigen Presentation

  • Eugenia S. Mardanova,
  • Egor A. Vasyagin,
  • Kira G. Kotova,
  • Gergana G. Zahmanova and
  • Nikolai V. Ravin

8 July 2024

A wide range of virus-like particles (VLPs) is extensively employed as carriers to display various antigens for vaccine development to fight against different infections. The plant-produced truncated variant of the hepatitis E virus (HEV) coat protei...

(This article belongs to the Special Issue Viruses and Virus-Like Particles as Nanoplatforms for Vaccines, Diagnostic and Therapeutic Nanomedicine)
  • Communication
  • Open Access
17 Citations
4,968 Views
8 Pages

Construction and Immunogenicity of Virus-Like Particles of Feline Parvovirus from the Tiger

  • Cuicui Jiao,
  • Hongliang Zhang,
  • Wei Liu,
  • Hongli Jin and ,
  • Di Liu,
  • Jian Zhao,
  • Na Feng,
  • Chuanmei Zhang and
  • Jing Shi
  • + 4 authors+ 0 author

16 March 2020

Feline panleukopenia, caused by feline parvovirus (FPV), is a highly infectious disease characterized by leucopenia and hemorrhagic gastroenteritis that severely affects the health of large wild Felidae. In this study, tiger FPV virus-like particles...

(This article belongs to the Special Issue Advances in Parvovirus Research 2020)
  • Article
  • Open Access
2 Citations
1,898 Views
17 Pages

Immunogenicity of Virus-like Particles Based on VP1 Protein of Bovine Norovirus

  • Zhigang Ma,
  • Xuelian Ma,
  • Xinyu Tao,
  • Yong Huang and ,
  • Qian Jiang,
  • Xiaojun Ding,
  • Fang Min,
  • Yichen Chu,
  • Ru Li and
  • Gang Yao
  • + 9 authors+ 4 authors

24 August 2025

Bovine Norovirus (BNoV) is a member of the enterovirus family that can cause gastroenteritis in calves. This virus poses a significant risk to calf growth and development as well as to the long-term sustainability of the cattle industry in China and...

  • Opinion
  • Open Access
4 Citations
4,209 Views
16 Pages

Can Virus-like Particles Be Used as Synergistic Agent in Pest Management?

  • Caroline Deshayes,
  • Anne-Sophie Gosselin-Grenet,
  • Mylène Ogliastro,
  • Bruno Lapied and
  • Véronique Apaire-Marchais

30 April 2022

Among novel strategies proposed in pest management, synergistic agents are used to improve insecticide efficacy through an elevation of intracellular calcium concentration that activates the calcium-dependent intracellular pathway. This leads to a ch...

(This article belongs to the Special Issue Insect Viruses and Pest Management 2.0)
  • Article
  • Open Access
43 Citations
6,756 Views
8 Pages

Production of SARS-CoV-2 Virus-Like Particles in Insect Cells

  • Youjun Mi,
  • Tao Xie,
  • Bingdong Zhu,
  • Jiying Tan and ,
  • Xuefeng Li,
  • Yanping Luo,
  • Fei Li,
  • Hongxia Niu,
  • Jiangyuan Han and
  • Juan Wang
  • + 6 authors+ 1 author

Coronavirus disease (COVID-19) causes a serious threat to human health. Virus-like particles (VLPs) constitute a promising platform in SARS-CoV-2 vaccine development. In this study, the E, M, and S genes were cloned into multiple cloning sites of a n...

(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)
  • Article
  • Open Access
23 Citations
4,398 Views
10 Pages

11 April 2021

Porcine epidemic diarrhea (PED), a highly contagious and lethal enteric disease in piglets, is characterized by diarrhea, vomiting, and dehydration, with high mortality in neonatal piglets. Despite the nationwide use of attenuated and inactivated vac...

  • Article
  • Open Access
77 Citations
7,913 Views
12 Pages

Evaluation of Three Morphologically Distinct Virus-Like Particles as Nanocarriers for Convection-Enhanced Drug Delivery to Glioblastoma

  • Joel A. Finbloom,
  • Ioana L. Aanei,
  • Jenna M. Bernard,
  • Sarah H. Klass and ,
  • Susanna K. Elledge,
  • Kenneth Han,
  • Tomoko Ozawa,
  • Theodore P. Nicolaides,
  • Mitchel S. Berger and
  • Matthew B. Francis
  • + 5 authors+ 0 author

5 December 2018

Glioblastoma is a particularly challenging cancer, as there are currently limited options for treatment. New delivery routes are being explored, including direct intratumoral injection via convection-enhanced delivery (CED). While promising, convecti...

(This article belongs to the Special Issue Virus-Based Nanomaterials and Nanostructures)
  • Article
  • Open Access
23 Citations
6,822 Views
13 Pages

A Replicating Viral Vector Greatly Enhances Accumulation of Helical Virus-Like Particles in Plants

  • Eva C. Thuenemann,
  • Matthew J. Byrne,
  • Hadrien Peyret,
  • Keith Saunders and ,
  • Roger Castells-Graells,
  • Inmaculada Ferriol,
  • Mattia Santoni,
  • John F. C. Steele,
  • Neil A. Ranson and
  • George P. Lomonossoff
  • + 7 authors+ 2 authors

11 May 2021

The production of plant helical virus-like particles (VLPs) via plant-based expression has been problematic with previous studies suggesting that an RNA scaffold may be necessary for their efficient production. To examine this, we compared the accumu...

(This article belongs to the Section Viruses of Plants, Fungi and Protozoa)
  • Article
  • Open Access
2 Citations
3,823 Views
13 Pages

Development of a Platform for Noncovalent Coupling of Full Antigens to Tobacco Etch Virus-Like Particles by Means of Coiled-Coil Oligomerization Motifs

  • Lorena Zapata-Cuellar,
  • Jorge Gaona-Bernal,
  • Carlos Alberto Manuel-Cabrera,
  • Moisés Martínez-Velázquez and ,
  • Carla Sánchez-Hernández,
  • Darwin Elizondo-Quiroga,
  • Tanya Amanda Camacho-Villegas and
  • Abel Gutiérrez-Ortega
  • + 3 authors+ 0 author

23 July 2021

Virus-like particles are excellent inducers of the adaptive immune response of humans and are presently being used as scaffolds for the presentation of foreign peptides and antigens derived from infectious microorganisms for subunit vaccine developme...

(This article belongs to the Special Issue Protein-Protein Interactions 2021)
  • Review
  • Open Access
14 Citations
5,948 Views
21 Pages

Virus-like Particles as Vaccines for Allergen-Specific Therapy: An Overview of Current Developments

  • Helena Berreiros-Hortala,
  • Gonzalo Vilchez-Pinto,
  • Araceli Diaz-Perales,
  • Maria Garrido-Arandia and
  • Jaime Tome-Amat

Immune engineering and modulation are the basis of a novel but powerful tool to treat immune diseases using virus-like particles (VLPs). VLPs are formed by the viral capsid without genetic material making them non-infective. However, they offer a wid...

(This article belongs to the Special Issue Deciphering Allergies—Structural and Immunological Characterization of Allergenic Proteins and Immunomodulatory Agents)
  • Feature Paper
  • Review
  • Open Access
8 Citations
5,078 Views
23 Pages

Virus-like particles (VLPs) exhibit such unique colloidal and structural properties that make them ideal candidates for various bio-nanotechnology applications, among which mucosal vaccination is particularly promising. However, since mucosal surface...

(This article belongs to the Special Issue Biocolloids and Biointerfaces: 2nd Edition)
  • Article
  • Open Access
6 Citations
8,412 Views
13 Pages

A Flow-Through Chromatographic Strategy for Hepatitis C Virus-Like Particles Purification

  • Ricardo J. S. Silva,
  • Mafalda G. Moleirinho,
  • Ana S. Moreira,
  • Alex Xenopoulos and ,
  • Paula M. Alves,
  • Manuel J. T. Carrondo and
  • Cristina Peixoto
  • + 2 authors+ 0 author

8 January 2020

Biopharmaceuticals are currently becoming one of the fastest growing segments of the global pharmaceutical industry, being used in practically all branches of medicine from disease treatment to prevention. Virus-like particles (VLP) hold tremendous p...

(This article belongs to the Section Biological Processes and Systems)
  • Article
  • Open Access
36 Citations
6,262 Views
13 Pages

Construction and Immunogenicity of Novel Chimeric Virus-Like Particles Bearing Antigens of Infectious Bronchitis Virus and Newcastle Disease Virus

  • Xuan Wu,
  • Xiwen Zhai,
  • Yan Lai,
  • Lei Zuo and ,
  • Yu Zhang,
  • Xueran Mei,
  • Rong Xiang,
  • Zhuangzhuang Kang,
  • Long Zhou and
  • Hongning Wang
  • + 5 authors+ 0 author

13 March 2019

Infectious bronchitis virus (IBV) and Newcastle disease virus (NDV) are two poultry pathogens seriously affecting the poultry industry. Here, IBV S1 and the ectodomain of NDV F proteins were separately linked with the trans-membrane and carboxy-termi...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
4 Citations
1,681 Views
15 Pages

11 October 2025

Virus-like particles (VLPs) formed as a result of self-assembly of viral capsid proteins are widely used as a platform for antigen presentation in vaccine development. However, since the inclusion of a foreign peptide into the capsid protein can alte...

(This article belongs to the Special Issue Recent Advances in Peptide Assembly and Bioactivity)
  • Article
  • Open Access
3 Citations
2,177 Views
13 Pages

Generation and Immunogenicity of Virus-like Particles Based on the Capsid Protein of a Chinese Epidemic Strain of Feline Panleukopenia Virus

  • Erkai Feng,
  • Guoliang Luo,
  • Chunxia Wang,
  • Wei Liu and ,
  • Ruxun Yan,
  • Xue Bai and
  • Yuening Cheng
  • + 2 authors+ 0 author

Feline panleukopenia (FPL), caused by the feline panleukopenia virus (FPLV), is a severe and highly contagious viral disease with high morbidity and mortality. Vaccination remains the gold standard for preventing and controlling this debilitating con...

(This article belongs to the Special Issue Gastrointestinal Disease and Health in Pets)
  • Article
  • Open Access
9 Citations
5,259 Views
15 Pages

Virus-Like Particles Produced Using the Brome Mosaic Virus Recombinant Capsid Protein Expressed in a Bacterial System

  • Aleksander Strugała,
  • Jakub Jagielski,
  • Karol Kamel,
  • Grzegorz Nowaczyk and ,
  • Marcin Radom,
  • Marek Figlerowicz and
  • Anna Urbanowicz
  • + 2 authors+ 0 author

Virus-like particles (VLPs), due to their nanoscale dimensions, presence of interior cavities, self-organization abilities and responsiveness to environmental changes, are of interest in the field of nanotechnology. Nevertheless, comprehensive knowle...

(This article belongs to the Special Issue Designer Biopolymers: Self-Assembling Proteins and Nucleic Acids 2020)
  • Review
  • Open Access
48 Citations
15,186 Views
23 Pages

Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery

  • Vartika Srivastava,
  • Kripa N. Nand,
  • Aijaz Ahmad and
  • Ravinder Kumar

18 February 2023

Virus-like particles (VLPs) are empty, nanoscale structures morphologically resembling viruses. Internal cavity, noninfectious, and particulate nature with a high density of repeating epitopes, make them an ideal platform for vaccine development and...

(This article belongs to the Special Issue New Trends in Vaccine Characterization, Formulations, and Development)
  • Review
  • Open Access
18 Citations
7,606 Views
25 Pages

20 December 2024

The capsid proteins of many viruses are capable of spontaneous self-assembly into virus-like particles (VLPs), which do not contain the viral genome and are therefore not infectious. VLPs are structurally similar to their parent viruses and are there...

(This article belongs to the Section Plant Genetics, Genomics and Biotechnology)
  • Article
  • Open Access
9 Citations
3,542 Views
14 Pages

Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity

  • Sucheta D’Sa,
  • Kimberly Braz Gomes,
  • Grace Lovia Allotey-Babington,
  • Cemil Boyoglu and ,
  • Sang-Moo Kang and
  • Martin J. D’Souza
  • + 1 author+ 0 author

10 April 2022

No approved vaccines against respiratory syncytial virus (RSV) infections exist to date, due to challenges arising during vaccine development. There is an unmet need to explore novel approaches and a universal strategy to prevent RSV infections. Prev...

(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles-2nd Edition)
  • Article
  • Open Access
826 Views
16 Pages

Virus-like Particles Derived from Bacteriophage Beihai32 as a Versatile Carrier for Displaying Large Peptide Antigens

  • Anna A. Zykova,
  • Elena A. Blokhina,
  • Marina A. Shuklina,
  • Olga O. Ozhereleva and ,
  • Sergey A. Klotchenko,
  • Eugenia S. Mardanova and
  • Nikolai V. Ravin
  • + 2 authors+ 0 author

29 July 2026

Virus-like particles (VLPs) based on the capsid protein (CP) of the ssRNA bacteriophage Beihai32 represent a promising nanoscale platform for the presentation of heterologous peptides. Previous studies have shown that the C-terminus of the CP tolerat...

(This article belongs to the Special Issue Nanoparticles as Platforms for Pharmaceuticals and Medicines)
  • Article
  • Open Access
16 Citations
5,246 Views
17 Pages

Production and Characterisation of Stabilised PV-3 Virus-like Particles Using Pichia pastoris

  • Lee Sherry,
  • Keith Grehan,
  • Jessica J. Swanson,
  • Mohammad W. Bahar and ,
  • Claudine Porta,
  • Elizabeth E. Fry,
  • David I. Stuart,
  • David J. Rowlands and
  • Nicola J. Stonehouse
  • + 4 authors+ 0 author

30 September 2022

Following the success of global vaccination programmes using the live-attenuated oral and inactivated poliovirus vaccines (OPV and IPV), wild poliovirus (PV) is now only endemic in Afghanistan and Pakistan. However, the continued use of these vaccine...

(This article belongs to the Special Issue Rosalind Franklin's 100th Birthday)
  • Article
  • Open Access
6 Citations
4,789 Views
12 Pages

Self-Assembly of Porcine Parvovirus Virus-like Particles and Their Application in Serological Assay

  • Yanfei Gao,
  • Haiwei Wang,
  • Shanghui Wang,
  • Mingxia Sun and ,
  • Zheng Fang,
  • Xinran Liu,
  • Xuehui Cai and
  • Yabin Tu
  • + 3 authors+ 0 author

20 August 2022

Porcine parvovirus (PPV) is widely prevalent in pig farms. PPV is closely related to porcine respiratory disease complex (PRDC) and porcine circovirus disease (PCVD), which seriously threatens the healthy development of the pig industry. Although com...

(This article belongs to the Special Issue Advances in Parvovirus Research 2022)
  • Article
  • Open Access
13 Citations
6,380 Views
17 Pages

Salmonella Vaccine Vector System for Foot-and-Mouth Disease Virus and Evaluation of Its Efficacy with Virus-Like Particles

  • Yong Zhi,
  • Hyun Jung Ji,
  • Huichen Guo,
  • Jae Hyang Lim and ,
  • Eui-Baek Byun,
  • Woo Sik Kim and
  • Ho Seong Seo
  • + 2 authors+ 0 author

5 January 2021

Foot-and-mouth disease virus (FMDV) causes a highly contagious and devastating disease in livestock animals and has a great potential to cause severe economic loss worldwide. The major antigen of FMDV capsid protein, VP1, contains the major B-cell ep...

(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)
  • Article
  • Open Access
11 Citations
4,636 Views
11 Pages

Japanese encephalitis virus (JEV) is classified into five genotypes labelled I through V. Although the genotype V (GV) JEV was originally found and had apparently been limited in Malaysia for more than 50 years, its emergence in Korea and China has r...

(This article belongs to the Section Vaccines Against Tropical and Other Infectious Diseases)
  • Article
  • Open Access
36 Citations
5,977 Views
17 Pages

Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses

  • Yongping Yang,
  • Wei Shi,
  • Olubukola M. Abiona,
  • Alexandra Nazzari and ,
  • Adam S. Olia,
  • Li Ou,
  • Emily Phung,
  • Tyler Stephens,
  • Yaroslav Tsybovsky and
  • Peter D. Kwong
  • + 20 authors+ 15 authors

21 January 2021

The COVID-19 pandemic highlights an urgent need for vaccines that confer protection from SARS-CoV-2 infection. One approach to an effective COVID-19 vaccine may be through the display of SARS-CoV-2 spikes on the surface of virus-like particles, in a...

(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)
  • Article
  • Open Access
2 Citations
3,354 Views
20 Pages

Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes

  • Yongping Yang,
  • Wing-Pui Kong,
  • Cuiping Liu,
  • Tracy J. Ruckwardt and ,
  • Yaroslav Tsybovsky,
  • Lingshu Wang,
  • Shuishu Wang,
  • Daniel W. Biner,
  • Man Chen and
  • Peter D. Kwong
  • + 19 authors+ 14 authors

31 August 2023

New vaccine delivery technologies, such as mRNA, have played a critical role in the rapid and efficient control of SARS-CoV-2, helping to end the COVID-19 pandemic. Enveloped virus-like particles (eVLPs) are often more immunogenic than protein subuni...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
3 Citations
4,328 Views
18 Pages

Foot-and-Mouth Disease Virus-like Particles Produced in E. coli as Potential Antigens for a Novel Vaccine

  • Sang-Cheol Yu,
  • In-Kyu Lee,
  • Hyun-Seok Kong,
  • Sung-Ho Shin and ,
  • Sung-Yoon Hwang,
  • Yu-Jin Ahn,
  • Jong-Hyeon Park,
  • Bong-Yoon Kim and
  • Young-Cheon Song
  • + 4 authors+ 0 author

Foot-and-mouth disease virus (FMDV) continues to pose a significant threat to livestock health and the global agricultural economy, particularly in endemic regions of Asia, Africa, and the Middle East. Current vaccines based on chemically inactivated...

  • Article
  • Open Access
580 Views
33 Pages

Comparative Evaluation of Plant-Derived Virus-like Particles as Intratumoral Immunotherapy Agents

  • Anete Ogrina-Komarova,
  • Zane Kalnina,
  • Rebeka Racina,
  • Vilija Zeltina and ,
  • Ramona Petrovska,
  • Ina Balke,
  • Patricija Zaremba,
  • Krista Resne,
  • Juris Jansons and
  • Andris Zeltins
  • + 5 authors+ 0 author

12 August 2026

Background: Plant-derived virus-like particles (VLPs) are emerging nanoplatforms for local cancer immunotherapy, yet their relative performance across structurally distinct particles remains insufficiently defined. Methods: We performed a comparative...

(This article belongs to the Special Issue Next-Generation Platforms for Vaccine Design and Immune Evaluation)
  • Article
  • Open Access
26 Citations
8,705 Views
19 Pages

Chimeric Rabies Virus-Like Particles Containing Membrane-Anchored GM-CSF Enhances the Immune Response against Rabies Virus

  • Hongtao Kang,
  • Yinglin Qi,
  • Hualei Wang,
  • Xuexing Zheng and ,
  • Yuwei Gao,
  • Nan Li,
  • Songtao Yang and
  • Xianzhu Xia
  • + 3 authors+ 0 author

11 March 2015

Rabies remains an important public health threat in most developing countries. To develop a more effective and safe vaccine against rabies, we have constructed a chimeric rabies virus-like particle (VLP), which containing glycoprotein (G) and matrix...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
2 Citations
5,429 Views
22 Pages

Kinetic Landscape of Single Virus-like Particles Highlights the Efficacy of SARS-CoV-2 Internalization

  • Aleksandar Atemin,
  • Aneliya Ivanova,
  • Wiley Peppel,
  • Rumen Stamatov and ,
  • Rodrigo Gallegos,
  • Haley Durden,
  • Sonya Uzunova,
  • Michael D. Vershinin,
  • Saveez Saffarian and
  • Stoyno S. Stoynov
  • + 5 authors+ 0 author

22 August 2024

The efficiency of virus internalization into target cells is a major determinant of infectivity. SARS-CoV-2 internalization occurs via S-protein-mediated cell binding followed either by direct fusion with the plasma membrane or endocytosis and subseq...

(This article belongs to the Special Issue Emerging Concepts in SARS-CoV-2 Biology and Pathology 2.0)
  • Article
  • Open Access
4 Citations
4,268 Views
15 Pages

5 February 2025

Enzymes play an essential role in many different industries; however, their operating conditions are limited due to the loss of enzyme activity in the presence of proteases and at temperatures significantly above physiological conditions. One way to...

  • Article
  • Open Access
1,573 Views
18 Pages

Targeting Dendritic Cells with Virus-like Particles: Toward Safer and More Immunogenic Vaccines

  • Jonny Jonny,
  • Chairul A. Nidom,
  • Terawan A. Putranto,
  • Soetojo Wirjopranoto and ,
  • I Ketut Sudiana,
  • Elisa D. Pratiwi,
  • Tiza W. Mawaddah,
  • Astria N. Nidom,
  • Reviany V. Nidom and
  • Astrid D. Larasati
  • + 7 authors+ 2 authors

6 November 2025

Background/Objectives: The dengue virus remains endemic in over 100 countries, transmitted by mosquito bites. Current management relies on supportive care, as no highly effective vaccine or approved antiviral exists. The CYD-TDV (Dengvaxia®) vacc...

(This article belongs to the Section Vaccines, Clinical Advancement, and Associated Immunology)

of 22